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Abstract 
Although the Addiction Severity Index (ASI) is one of the most frequently used measures in alcohol and 
other drug research, it has rarely been used to assess clinical and reliable change. This study assessed 
clients' clinical and reliable change at The Salvation Army residential substance abuse treatment centers 
in Australia. A total of 296 clients completed ASI interviews on admission to treatment and 3 months 
after discharge from treatment. Clients demonstrated significant improvement on all seven ASI 
composites. The range of reliable change for each ASI composite varied from 30% to 70%. More than 
two-thirds of clients experienced clinically significant improvement for alcohol and drug problems. 
Psychiatric distress was clinically reduced in 44% of clients. This research indicates that residential 
substance abuse treatment can make important differences in client's lives at a clinical and functional 
level. However, the research highlights the challenge of effectively targeting psychiatric comorbidity 
within alcohol and other drug abuse populations. 
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Although the Addiction Severity Index (ASI) is one of the most frequently used measures in 
alcohol and other drug (AOD) research, it has rarely been used to assess clinical and reliable 
change. This study assessed clients’ clinical and reliable change at The Salvation Army 
residential substance abuse treatment centres, Australia. 296 clients completed ASI 
interviews upon admission to treatment and three months after discharge from treatment. 
Clients demonstrated significant improvement on all seven ASI composites. The range of 
reliable change for each ASI composite varied from 30%-70%. Over two thirds of clients 
experienced clinically significant improvement for alcohol and drug problems. Psychiatric 
distress was clinically reduced in 44% of clients. This research indicates that residential 
substance abuse treatment can make important differences in client’s lives at a clinical and 
functional level. However, the research highlights the challenge of effectively targeting 
psychiatric co-morbidity within AOD abuse populations. 
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Clinical and Reliable Change in an Australian Residential Substance Use Program Using the 
Addiction Severity Index 
Longitudinal research that measures change in substance abuse populations is relatively 
common. Such research provides evidence that interventions aimed at reducing and 
eliminating substance abuse and improving functioning in various life domains are making 
significant change in groups of people with alcohol and other drug (AOD) addictions, at least 
from a statistical perspective (Slaymaker & Owen, 2006; Watkins, et al., 2011).  
While such research is important, it does not reveal whether the magnitude of change is 
clinically meaningful (Burgess, Pirkis, & Coombs, 2009). Specifically, a comparison of 
means from pre-intervention to post-intervention usually only reflects group differences and 
statistical change. With sufficient numbers of participants small but consistent changes may 
be statistically significant but offer less in terms of changes in an individual’s overall 
experience of illness or recovery.  That is, there may not be any functional change in the 
individual’s lifestyle. A group of people abusing alcohol or other drugs may reduce their 
substance use significantly compared to a control group (or their prior use), yet the treatment 
group may still be experiencing substance abuse habits and issues consistent with those still 
meeting the criteria for a substance use disorder diagnosis. Thus a change in group means 
tells us little about the meaningfulness of that change, and also fails to discriminate between 
those individuals who are changing or who are not changing within the group (Bowersox, 
Saunders, & Wojcik, 2009). Jacobson and Truax (1991) also indicated that analysis of group 
means typically provides a less conservative suggestion of intervention effectiveness that 
fails to consider actual improvement when contrasted with group mean differences. In short, 
tests of statistical significance provide information at the group level but indicate nothing 
about the number of individuals who have made clinical and reliable improvement in the 
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assessed domain (Hiller, Schindler, & Lambert, 2012; Jacobson & Truax, 1991), a critical 
consideration when reviewing outcome measures after treatment (Burgess et al., 2009).  
Clinical and Reliable change 
Clinical and reliable improvement goes beyond a simple comparison of group means, and 
instead determines the efficacy of an intervention in moving a person from being classified as 
experiencing problems in a given area to being considered within a ‘normal’ population on 
that variable after following treatment (Bowersox et al., 2009; Jacobson & Truax, 1991; 
Speer & Greenbaum, 1995; Westbrook & Kirk, 2005). It also shows that such change is 
reliably beyond any error in measurement (Bowersox et al., 2009; Hiller et al., 2012; Ogles, 
Lambert, & Masters, 1996). The purpose of this paper is to explore the extent to which 
clinical and reliable change is demonstrated in clients receiving residential services provided 
by The Salvation Army in Australia for alcohol and other drug addictions. The Addiction 
Severity Index (ASI) was used as the central measurement tool for this study. 
Research that is conducted to test for clinical and reliable change assesses change at the 
level of the individual, and allows advantages over standard tests of group means. These 
advantages might include organisational benchmarking (Billingham, et al., in press) and 
summaries of the percentage of clients who improve, deteriorate, or make no clinical 
improvements. This information can be useful within an organisation to assess treatment 
efficacy, but also to assess performance of individual units within an organisation, or to 
compare treatment efficacy with other organisations who publish data on their own 
performance (Kelly, 2010).  
There are multiple methods for computing clinical and reliable change, although the 
Jacobson-Truax method is the most commonly used and accepted method (Jacobson & 
Truax, 1991; Lopez-Goni, et al., 2010; Speer & Greenbaum, 1995, 2002).  Jacobson and 
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Truax (1991) suggest three methods for calculating clinical change. The first (criterion a) 
requires clients who score in a clinical range on a specific variable of interest at baseline to 
move two standard deviations away from the clinical mean at follow up. Criterion b requires 
clients to fall within two standard deviations of the ‘normal’ population mean at follow up. 
Criterion c is the most stringent of Jacobson and Truax’s (1991) alternatives, and requires 
that clients move so as to be closer to the normal population mean than the (baseline) clinical 
mean at follow up. 
The value of assessing clinical and reliable change has been asserted consistently over the 
past decade (Billingham et al., in press; Bowersox et al., 2009), although there is still limited 
use of these types of analyses in the majority of studies conducted assessing substance abuse 
treatment efficacy. Only a small percentage of studies consider such change based on clinical 
and reliable change (Billingham et al., in press; Burgess et al., 2009; Hiller et al., 2012). By 
using clinical and reliable change as a standard by which to assess change, organisations can 
benchmark their treatment effectiveness, and track progress over time. 
The Addiction Severity Index and reliable change 
The Addiction Severity Index (ASI) is one of the world’s most widely used and 
researched assessments of functioning in AOD clients (McLellan, Cacciola, Alterman, 
Rikoon, & Carise, 2006). The measure consists of structured interview questions assessing 
client functioning across seven domains (e.g., drug, alcohol, psychiatric). While the ASI is 
widely used, we found no longitudinal analyses of residential AOD treatment clients that 
assessed clinical and reliable change on ASI composite scores, though some have used the 
reliable change index alone (Bodin & Romelsjo, 2007; Lopez-Goni et al., 2010).  
Lopez-Goni et al. (2010) investigated change in 112 drug abusers who remained in a 
Spanish inpatient community for the duration of a 12-month rehabilitation program and 
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assessed the extent to which reliable change was demonstrated by the participants. There was 
substantial variation in the extent to which clients experienced reliable change in the various 
ASI domains, with change ranging from 7.9% of participants (in the family/social domain) to 
66.7% of participants (in the alcohol consumption domain). Across all variables, a total of 
less than 10% of participants demonstrated reliable deterioration after treatment.  
Similar results were obtained by Bodin and Romelsjo (2007), who used the RCI to 
demonstrate reductions in problem severity across five of the seven ASI domains. Of the 188 
alcohol abusers in the study, 70.7% of clients who indicated alcohol problem severity in a 
range that would allow for reliable improvement were found to make such improvement. 
Only 13.8% of those who could reliably improve their drug problem severity scores who did 
so. Further reliable improvements were obtained in areas of secondary concern including 
family (11.2%), psychiatric (18.6%), and legal (12.2%) problem severity. No significant 
improvement was found for medical and employment domains for these participants.  
Research was also conducted by Currie et al. (2003) who used the ASI to analyse 
substance abusers experiencing chronic pain. They found highly statistically significant 
differences in mean alcohol scores from admission to follow up. Such comparison of group 
means, however, does not indicate the proportion of participants who improve, do not 
change, or who deteriorate. When using the RCI to demonstrate change, this statistical 
improvement equated to only between one quarter to one third of participants improving in 
various domains. To our knowledge, no studies have extended analysis from reliable change 
to clinically significant change for AOD treatment centre research. 
The present study 
We have found no previous longitudinal Australian research that has utilised the ASI for 
residential substance abuse clients. Moreover, there is a lack of research that assesses clinical 
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and reliable change in Australian samples of substance abusers more generally, using any 
measures. The present study reports the characteristics of residential substance abuse 
treatment-seeking clients based on ASI data and provides a comparison with normative data 
from the United States. The study will examine the effectiveness of The Salvation Army 
substance abuse residential recovery programs on an intention-to-treat basis, and analyse 
client outcomes in terms of their statistical significance, but also using the clinical and 
reliable change as a central metric of improvement, stability, or deterioration. This research 
advances our understanding of the clinical efficacy of such interventions in each of the seven 
domains assessed by the ASI. 
Method 
Participants 
 From November 2008 until April 2011, the ASI was administered to 1105 participants 
within 14 days of admission to a residential drug and alcohol treatment service operated by 
The Salvation Army. This process took place across eight individual service locations in New 
South Wales, Queensland, and the Australian Capital Territory. Participants provided 
informed consent before participating in this study and all protocols received review and 
approval of the University of Wollongong Human Research Ethics Committee. Males 
comprised 83.1% (n = 918) of the admission sample. Participants’ ages at admission ranged 
from 17 years to 73 years (M = 35.53, SD = 10.61). 
Follow-up data was collected from 296 of the original participants three months after 
leaving The Salvation Army Recovery Service. To be eligible for follow-up participation, 
clients must have completed an ASI within two weeks of admission to treatment, and must 
also have been a) available, b) willing to participate, and c) not have returned to treatment. 
The follow-up sample included 244 males (82.4%). Participants average age was 37.09 years 
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(SD = 10.99). Anglo-Australians were the dominant ethnic group (80.1%), and Aboriginal 
Australians (6.1%), English (3.4%) and New Zealand participants (2.7%) were the other 
major cultural groups represented in the sample. Average length of time in treatment was 107 
days (SD = 93.15). 
Those who chose to participate in the follow up ASI interview were no different at 
admission to those who did not participate in terms of age and ASI composite scores, except 
on the legal composite and the alcohol composite. Those who provided data at follow up had 
a significantly higher average alcohol composite score at admission (M = .44, SD = .29) 
compared to those who did not participate in the follow up interview (M = .39, SD = .30),  
t (1159) = -2.26, p = 02. Conversely, those who provided data at follow up had significantly 
lower legal composite score (M = .16, SD = .23) than those who did not participate in the 
follow up interview (M = .23, SD = .24), t (1159) = -2.26, p = 02. Chi-square analysis 
revealed no significant differences in gender distribution, culture/ethnicity, or primary drug 
of choice when comparing participants who provided data at admission only with participants 
who participated at the 3-month follow up. 
Measures 
 The Addiction Severity Index (ASI), version 5 (McLellan, et al., 1992), was 
administered to all participants within fourteen days of their admission to one of the agency’s 
participating residential centres. The ASI is one of the most widely utilised substance abuse 
assessment tools in the world (Bodin & Romelsjo, 2007; McLellan et al., 2006; McLellan, 
Kushner, Metzger, Peters, & et al., 1992). It is a semi-structured interview that explores seven 
domains of functioning: medical history and status, employment, alcohol and other drug use 
and history, legal issues, family and social relationships, and psychiatric history and status. 
The ASI is used to obtain information from participants about their involvement in each of 
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these domains for the past 30 days. In each domain the 30-day data is combined via a formula 
(see McGahan, Griffith, Parente, & McLellan, 1986)  to produce a non-standardised 
composite score (CS) ranging from .00 to 1.00. Higher scores indicate higher levels of 
dysfunction within the relevant domain.  
The ASI has good internal consistency, test-retest reliability, and satisfactory validity 
(Alterman, Brown, Zaballero, & McKay, 1994; Stoffelmayr, Mavis, & Kasim, 1994). 
However there is some variability in findings regarding the ASI’s psychometric properties, 
with more positive outcomes reported by the tool’s creators (McLellan, Kushner, Metzger, 
Peters, Smith et al., 1992) compared to others seeking to replicate their work (McCusker, 
Bigelow, Servigon, & Zorn, 1994; Stoffelmayr et al., 1994). Nonetheless, research by 
Stöffelmayr et al. (1994) indicates that composite scores (which are particularly relevant for 
this study) show good longitudinal stability. 
Procedure 
 A member of the research team (PK) trained The Salvation Army staff in ASI 
delivery utilising the Addiction Severity Index Module of the United Nations Drug 
Dependence Treatment Training Package (UNODC, n.d.). Training incorporated one day of 
direct instruction, group discussion, and role-plays. It was followed up with a booster session 
approximately 6-months after initial training. The Salvation Army incorporated the use of the 
ASI into routine operating procedures at each of the recovery service centres. Case managers 
were instructed to complete the ASI during the person’s first seven days of residential care. 
As a result of work demands, on some occasions there were delays in the interview being 
completed. Consequently the present analysis allows a timeframe of up to two weeks for ASI 
interviews to have been completed. All data were entered into The Salvation Army 
Management Information System (SAMIS) and downloaded for analysis in PASW v19.  
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Follow up interviews were conducted by trainer research assistants via telephone and 
occurred three months after participants had left residential care, whether they successfully 
completed treatment or not (i.e., intention to treat). 
Analysis 
ASI composite scores were the variables of interest in this study. Statistical change 
was measured using t-tests, comparing ASI composite scores at admission and 3 month 
follow up. Based on the recommendation of Speer and Greenbaum (1995, 2002) and more 
recent analysis from Lopez-Goni et al. (2010) the RCI calculations were based on the formula 
derived from Jacobson and Truax (1991). This formula is as follows:  
RCI = (X2 – X1) /(2 [SD (1 – rxx) ½]2)½ where X1 and X2 represent the admission and 3 
month follow up scores respectively, SD is the standard deviation of admission ASI data, and 
rxx is the test-retest reliability coefficient for the relevant ASI composite. The smaller the 
standard deviation of outcome scores and the higher the reliability of the instrument, the 
smaller the change that is required from admission to follow up to demonstrate reliable 
change in the individual. Reliable change is more difficult to demonstrate when measurement 
error increases and the associated variance in outcome data increases. Scores greater than or 
less than 1.96 (i.e., the 95% range) indicate reliable change in either the positive or negative 
direction (Hiller et al., 2012; Lambert & Ogles, 2009). Thus a person can be said to have 
changed reliably from admission to follow up by analysing a function of the measure’s 
standard deviation and reliability, in this case its test-retest reliability.  
Test-retest scores for this analysis were based on research by McCusker et al. (1994), 
who provided the following six composite test-retest correlation coefficients: alcohol = .84, 
drugs = .85, psychiatric = .52, employment = .83, legal = .83, and medical = .51. Because 
McCusker et al. did not provide a correlation for the family/social composite (due to protocol 
CLINICAL AND RELIABLE ASI CHANGE 
11 
 
errors) the coefficient, r = .63, provided by Bodin and Romelsjo (2007) and Daeppen et al. 
(1996) was utilised in this analysis. McCusker et al.’s (1994) data was chosen because the 
sample incorporated drug abusers whereas Daeppen et al. (1996) and Bodin and Romelsjo 
(2007) focused on alcohol abusers alone. Moreover, as the test-retest reliability in McCusker 
et al.’s (1994) data is lower (i.e., higher measurement error), the analysis is more stringent 
because reliable improvement needs to be greater in order to exceed that larger error 
allowance (Bodin & Romelsjo, 2007). 
Clinically significant change was measured according to the most stringent criterion 
advocated by Jacobson and Truax (1991); criterion c. Only clients who were measured as 
closer to the clinical mean for a given variable at admission to treatment were included in this 
analysis, which was conducted using the formula: 
CS = (meanclin x SDnorm) + (meannorm x SDclin) 
(SDnorm + SDclin) 
In this instance, the meanclin and SDclin is the mean and standard deviation for the clinical 
population (the current study) at admission, and the meannorm and SDnorm is the mean and 
standard deviation for the non-clinical population. Normative data was taken from Weisner et 
al. (2000). Such data was available for four of the seven ASI composite scores (drug, alcohol, 
psychiatric, and medical). 
 Bowersox et al. (2009) indicated that some participants providing data as part of a 
clinical sample may not score in the clinical range. Moreover, some participants’ scores may 
preclude them from making significant or reliable change. Therefore, as indicated previously, 
analyses have been conducted using only those participants who scored within the clinical 
range on each composite score during their initial ASI interview upon admission to treatment.  




At admission, interviewers coded participants’ primary presenting addictions as 
follows: alcohol (54.8%), amphetamines/stimulants (15%), cannabis (13.6%), and heroin 
(8.2%). All other substances were reported as primary problems at rates of 1.6% or less. In 
the 30 days prior to admission, alcohol was the drug most likely to be consumed, followed by 
cannabis. Over three quarters of the sample had been previously treated for substance use or 
abuse. Smoking tobacco in the 30 days prior to admission was reported by 68.8% of clients. 
Mean number of cigarettes smoked per day was 12.83 (SD = 11.82). Approximately 80% of 
those admitted for treatment indicated either a history of depression or anxiety. More than 
half of the sample reported experiencing serious depression in the 30 days prior to admission, 
and 70% reported having experienced serious anxiety or tension in the same timeframe (see 
Table 1). 
<<< INSERT TABLE 1 ABOUT HERE>>> 
Table 2 provides an overview of demographic characteristics of the sample at 
admission and at follow up, along with data for comparison from a sample of inpatients 
receiving AOD treatment in the United States from McLellan et al. (2006). This comparison 
reveals that the present sample reported greater problem severity across all seven ASI 
domains in contrast to the USA sample. This was particularly noticeable in the psychiatric 
domain, where the present sample reported much higher rates of lifetime experience of 
depression, anxiety, and suicide attempts.  
<<< INSERT TABLE 2 ABOUT HERE>>> 
Group change from admission to follow up 
CLINICAL AND RELIABLE ASI CHANGE 
13 
 
A series of t-tests on composite scores demonstrated significant differences across all 
seven ASI domains, indicating statistically significant improvement for clients between 
admission and three months follow-up. T-scores were as follows: Alcohol, t (277) = 13.39,   
p < .001; Drug, t (173) = 9.64, p < .001; Psychiatric, t (274) = 7.93, p < .001; Employment,   
t (328) = 11.46, p < .001; Medical, t (275) = 6.38, p < .001; Family/Social,  t (265) = 6.54,  
p < .001; and Legal, t (278) = 6.39, p < .001. 
Reliable change 
Table 3 provides cutoff scores and reliable change indices for each of the ASI 
composite scores.  
<<< INSERT TABLE 3 ABOUT HERE>>> 
Table 4 illustrates that in the domains for which treatment was primarily being sought, 
reliable change was achieved for clients with alcohol problems in two-thirds of cases. For 
clients with other drug problems 70% showed a reliable change in scores in a positive 
direction. The five other domains assessed by the ASI showed varying proportions of reliable 
improvement for individual participants with the psychiatric composite offering the lowest 
rate of improvement. A small minority deteriorated in the alcohol and drug domains 
following treatment (see Table 4).  
<<< INSERT TABLE 4 ABOUT HERE>>> 
Clinical and reliable change 
The percentage of clients who achieved a reliable and clinically significant change is 
shown in Table 5. Of the total sample, change ranged from 31.5% to 47.9%. When only 
considering clients who presented with symptoms in the clinical range at baseline, the 
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percentages of those who experienced clinically significant and reliable change increased 
markedly, as did the range of change achieved (43.9% - 70.3%).  
<<< INSERT TABLE 5 ABOUT HERE >>> 
Correlation between ASI composite scores 
Table 6 provides the correlations between composite scores for each of the ASI 
domains at admission (below the diagonal) and follow up (above the diagonal). At admission 
the correlations were generally low, with few exceptions. A strong positive correlation was 
found between psychiatric and family composites, indicating that as psychiatric difficulties 
increased, so too did family problems. The same pattern was also shown between alcohol use, 
drug use, and psychiatric problems. All other correlations remained low in magnitude, 
although there were still many significant associations between composite scores. At follow 
up there were fewer significant correlations. Relationships between high alcohol and drug 
composites and high psychiatric composite scores were highly significant. A significant 
relationship was also found between alcohol and family composite scores. The psychiatric 
composite scores were significantly positively related to all six other ASI domains.  
<<< INSERT TABLE 6 ABOUT HERE >>> 
Discussion 
The purpose of this study was to examine ASI data from clients in The Salvation 
Army residential substance abuse treatment programme in comparison to previously 
published ASI data of other AOD treatment recipients from the USA. It also aimed to 
determine rates of change using statistical, as well as clinically significant and reliable change 
indices.  
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An international normative sample was described by McLellan et al. (2006) and 
provided data allowing comparisons with the Australian residential treatment sample. The 
present sample was higher than the comparison sample on all ASI composite scores 
indicating greater levels of distress and dysfunction in all seven areas assessed by the ASI 
when compared with a large overseas sample. Alcohol and other drug use composites were 
generally similar, though still higher in the present sample than in the McLellan et al. data. 
Reliable change for individual scores from admission to 3 month follow up 
When considering reliable change at an individual level, results indicate individual 
variability in response to treatment. Depending on the ASI composite of interest, up to 70% 
of symptomatic clients demonstrated improvement at follow up relative to their admission 
scores. The two best performing domains for reliable change were alcohol and drugs, which 
is understandable given the fact that clients were seeking treatment for difficulties in these 
areas. These outcomes suggest that two thirds of clients being admitted to The Salvation 
Army treatment programme experienced reductions in addiction by the three-month post-
discharge follow up. However, around 34% of clients did not demonstrate reliable 
improvement on the alcohol composite, and 30% did not improve on the drug composite, 
despite having scores at admission indicating that improvement toward a more positive 
degree of functioning was possible. Only a small percentage of those we were able to follow 
up with (3% and 2% respectively for alcohol and drugs) were found to have reliably 
deteriorated following discharge from the programme.  
Using reliable change as the benchmark for improvement is a far more conservative 
approach to assess improvement in substance abuse treatment. The Reliable Change Index 
indicated that 36.5% of clients experiencing reliable improvement in the family/social 
domain, and just under 30% of clients reliably improved in the psychiatric domain. These 
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results are important as they demonstrate the rates of meaningful change in individuals’ lives; 
changes that are easily overlooked in traditional statistical approaches based on assessing 
mean changes over time. The data are also consistent with research that has identified that 
clients who attend substance abuse treatment do not all require improvement in all life 
domains (Bodin & Romelsjo, 2007; Lopez-Goni et al., 2010), and that many are functional at 
‘normal’ levels in spite of their addictions.  
Correlations of composite scores 
Consistent with previous research (Bodin & Romelsjo, 2007) correlations of 
composite scores were generally low across domains. While many were significant, the 
magnitude of the correlations was small at admission with just two exceptions: psychiatric 
and alcohol composites (r = .33), and psychiatric and family/social composites (r = .47). At 
follow up the size and number of significant relationships between composites was reduced. 
Again the psychiatric composite was concerning, with significant positive associations with 
both drugs (r = .37) and alcohol (r = .39). The consistent significant relationship between 
psychiatric composite scores and other ASI domains also highlights the importance of 
addressing co morbidity in the sample. 
These findings highlight the importance of the issue of psychiatric co-morbidity in the 
AOD population. At admission psychiatric problem severity showed significant positive 
associations with problems in four of the six additional ASI domains, including drug and 
alcohol composites. By follow up this had increased to significant positive associations with 
all six of the other composites and the magnitude of those relationships had increased for 
drug, alcohol, employment, and legal composites. The present study attests to the highly 
complex difficulties experienced by those attending treatment for AOD abuse. Their drug 
addictions appear to co-occur with employment problems, psychiatric difficulties, social and 
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family issues, legal troubles, and poor physical health. This research highlights the degree to 
which these individuals are at risk, and the importance of ensuring that the treatment agencies 
are adequately and appropriately resourced to provide treatment, with particular need for 
increased emphasis on psychiatric co morbidity (Dawes, Sitharthan, Conigrave, Phung, & 
Weltman, 2011; Dingle & King, 2009; Lai & Huang, 2009; Nielsen, et al., 2011).  
Limitations 
 A limitation of the study is the short term follow up administration of the ASI. The 
interview occurred only three months post-discharge. It is possible that clients’ behavioural 
changes may be sustained in the short term following intervention, but that over time, the 
changes may be harder to maintain. This is particularly so if there are ongoing issues with 
cravings (Gordon, et al., 2006; Witkiewitz & Bowen, 2010), psychiatric difficulties such as 
depression or other mood disorders (Shaikh & Ghosh, 2011; Suter, Strik, & Moggi, 2011; 
Witkiewitz & Bowen, 2010), or a social or physical environment that discourages 
maintenance of new behaviours (Shaikh & Ghosh, 2011). Further follow up will be necessary 
to determine the maintenance of these outcomes, particularly in the primary focal area of 
substance abuse, but also in the secondary domains related to psychiatric, social, legal, 
medical, and employment. A further limitation of this study is that no control group is 
employed.  
Lastly, we have low follow-up rates. Some clients were unavailable for follow-up. 
This may have been due to the transient nature of many clients of services, relapse issues, or 
incarceration. Thus, the improvements we have obtained may be from a group of clients who 
were better placed to maintain their lifestyle changes when compared with those we were 
unable to contact to obtain follow-up data. Further, some clients were interviewed but 
provided no ASI data due to ‘time’ issues. As such, clients were ‘interviewed’ for five 
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minutes on as much as possible, but often not inclusive of the ASI. Follow ups were, 
therefore, higher, but just not for specific ASI data.  
Strengths 
 There are several strengths of this study. First, the study is the only research in 
Australia that we are aware of that utilises the ASI in a longitudinal manner to assess clinical 
and reliable change in AOD treatment service provision. The ASI’s utility in substance abuse 
treatment research is substantial (McLellan et al., 2006; McLellan, Kushner, Metzger, Peters, 
& et al., 1992; Stoffelmayr et al., 1994; Weisner et al., 2000). The ASI is a leading measure 
of AOD addiction internationally and allows comparison across other treatment settings and 
within the broader literature (McLellan et al., 2006). In particular, the comprehensive nature 
of the ASI demonstrates the differing outcomes that clients are experiencing following 
substance abuse treatment in multiple life domains. This is particularly useful information 
due to differences in health systems between countries which may mean different disorder 
and severity profiles. These need to be taken into account when benchmarking or in funding 
models for services. By using the ASI as a standard measure, such issues can be overcome 
through allowing description of the severity and complexity of particular treatment samples 
to be demonstrated in a standardised manner at a global level. 
Another important strength of this study relates to the limited use of clinical and 
reliable change to determine the proportion of clients who are achieving functional treatment 
outcomes provides valuable information for treatment service providers via the ASI. There is 
limited research that considers clinical and reliable change on ASI composite scores. 
Moreover, this research facilitates ongoing improvements in the work that The Salvation 
Army does in assessing and improving services for people seeking treatment for AOD 
addiction. Additionally, the use of this kind of analysis adds to the quality of arguments for 
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funding for residential treatment services by demonstrating clear results associated with 
treatment interventions. Last, the research highlights the critical role that psychiatric 
difficulty plays in functioning in all other aspects of these clients’ lives.   
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ASI Comparison Data: Summary Scores and Past 30-Day Data by Age, Gender, and 
Normative Sample at Admission and at Follow up 
 Inpatient 
McLellan et al. 2006 




(3-month follow up) 
Substance use    
Alcohol composite score .33 (.27) .41 (.30) .17 (.26) 
Mean days of alcohol drinking 8 (10) 8.45 (9.27) 4.74 (8.36) 
Mean days of heavy drinking† 5 (9) 7.66 (9.04) 3.13 (7.21) 
Drug composite score .11 (.14) .14 (.13) .04 (.09) 
Mean days of heroin use 2 (8) .87 (3.63) .28 (2.41) 
Mean days of cocaine use 3 (8) .28 (1.74) .01 (.08) 
Mean days of marijuana use 2 (6) 5.05 (8.57) 2.5 (7.13) 
Mean days of amphetamine use  1.66 (4.62) .48 (2.65) 
    
Personal health: medical    
Medical composite score .16 (.29) .30 (.33) .12 (.26) 
Mean days of medical problems 4 (9) 6.32 (10.52) 3.19 (7.83) 
    
Personal health: psychiatric    
Psychiatric composite score .20 (.24) .42 (.24) .29 (.25) 
% Reporting depression 31% 55.3% 43.2% 
% Reporting anxiety 35% 69.6% 54.1% 
Mean days of psychiatric problems 8 (12) 12.89 (12.71) 10.54 (11.32) 
    
Social functioning: employment    
Employment composite score .65 (.32) .77 (.20) .70 (.29) 
Mean days paid for working 8 (10) 2.16 (6.27) 3.88 (8.20) 
Mean days of employment problems 8 (12) 10.03 (13.70) 4.70 (12.72) 
    
Social functioning: family/social    
Family composite score .15 (.21) .30 (.24) .18 (.19) 
Mean days family conflicts 3 (8) 3.10 (7.39) 3.19 (7.89) 
Mean days social conflicts 2 (6) 1.61 (4.50) Na 
% Currently living with person with alcohol problem 13% 18.6% Na 
% Currently living with person using or abusing drugs 7% 15% Na 
    
Social functioning: legal    
Legal composite score .20 (.22) .22 (.24) .10 (.21) 
% in controlled environment 68% 23% 17.2 % 
Mean days illegal activity 1 (5) 1.39 (4.06) .06 (.47) 
Mean days incarcerated 2 (6) 4.22 (9.24) .19 (1.99) 
Note. All values are based upon the thirty days prior to the administration of the ASI. All values are means, with standard 
deviations in parentheses. * N varies from 614 (drug use composite) – 1105 (mean days paid for working) ** N varies from 292 








Demographic Characteristics and Lifetime ASI Data from a Normative Sample and the Current Study 
 Inpatients 
McLellan et al. 2006 
N = 8,429 
All* 
(Current sample at 
baseline) 
N = 1105 
Follow up sample 
(Lifetime or past 3 
years measures at 
baseline) 
N = 296 
Age yrs (SD) 36 (10) 35.5 (10.61) 37.09 (10.09) 
Gender % Male 61% 83.1% 83% 
Ethnicity 
% White (USA) or Anglo Australian (Aus) 
% Black or African American 













% Never married 
% Married or living as married 
% Separated or Divorced 
















Years of education 
% < 12 years 
% High school Graduate 
% Technical college/Trade/TAFE 
















Substance use    
% Previous drug and/or alcohol treatment 
% With past history of overdoses  
% Used heroin 
% Used cocaine 
















Personal health: medical 
% Reporting a chronic medical problem 










Personal health: psychiatric  
% Previously treated 
% Taking medications 
% Lifetime history of depression 
% Lifetime history of anxiety 



















Social functioning: Employment 







   Employment pattern, past 3 years 
     % Working (full-time or part-time) 










Social functioning: family/social 
Living situation past three years 
% With sexual partner 
% With family 
% With friends 
% Other living situation 
% Satisfied with living situation 
% Reporting physical abuse in lifetime 




























Social functioning: legal 
% Convicted of crime 










Note. * N varies from 735 (cocaine usage) – 1103 (gender) ** Data from past three months (post-discharge) 
 
  




Cut-off Scores and Reliable Change Index for ASI Composite Scores 
ASI Composite Cut-off b Reliable Change Index c 
Alcohol  .165 .33 
Drugs .034 .14 
Employment a - .24 
Family a - .42 
Medical .261 .74 
Psychiatric  .144 .46 
Legal a - .27 
Note. a Normed scores not available for calculating cut-off scores. b Cut-offs calculated using 
Jacobson and Truax (1991) criterion c. c Denotes the amount of movement required in scores from 
admission to follow up to be considered reliable change. 
 
  




Composite Score Means (SD’s), Number of Participants, and Reliable Change Following Intervention. 
 Group Means (SD’s)* Percentage of Participants with Reliable Change 
ASI-CS Admission 
(SD) 
Follow-Up N at admission 
(follow up) 
Improved Deteriorated No change Possible Cases† 







(n = 109) 
3 
(n = 5) 
30.9 










(n = 60) 
2 
(n = 2) 
28 
(n = 24) 
 
86 








(n = 136) 
9.7 
(n = 27) 
41.2 









(n = 27) 
0 63.5 










(n = 21) 
0 34.4 
(n = 11) 
 
32 







(n = 38) 
0 70.3 
(n = 90) 
 
128 







(n = 53) 
0 35.4 
(n = 29) 
82 
Note. a These data are based on modified composite scores due to follow up data not including all composite score questions. * All CS’s differ 
significantly when p < .001. † The total number of cases where data was provided and reliable improvement was possible. 
  




Clinically Significant Change on ASI Composite Scores: Total Sample and Sample with Asymptomatic Clients Removed. 





















Alcohol 47.9% 51.5% 1.6% 70.3% 29.7% N/A 
Drug 40.2% 39.2% .6% 67.1% 32.9% N/A 
Psychiatric 31.5% 66.33% 2.17% 43.9% 56.1% N/A 
 
  




Correlations of Composite Scores at Admission and Follow up 3 months After Leaving Residential Treatment 
 Alcohol Drug Psychiatric Employment Family Legal Medical 
Alcohol  .34** .39** .09 .30** .09 .07 
Drug .00  .37** .10 .11 .13* -.03 
Psychiatric .33** .24**  .13* .21** .13* .18** 
Employment -.07* .02 .00  .01 .08 .02 
Family .24** .23** .47** -.06  .06 .08 
Legal -.12** .10* -.02 -.09** .05  -.02 
Medical .15** .00 .23** .09** .10** -.03  
Note. N for Time 1 ranges from 825-937 on all variables except drug-related responses (ranging from 533-598). N for follow up ranges from 
294-296. * p < .05. ** p < .01. Admission scores are below the diagonal and follow-up scores are above the diagonal. 
